Novel nucleosides as potent influenza viral inhibitors
Novel nucleosides were synthesized from di benzoyl fluoro lactone ( 1) and evaluated their anti-influenza viral activity. Compound ( 18c) showed the best antiviral activity among the compounds synthesized. Influenza virus infection constitutes a significant health problem in need of more effective t...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2010-09, Vol.18 (17), p.6329-6339 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6339 |
---|---|
container_issue | 17 |
container_start_page | 6329 |
container_title | Bioorganic & medicinal chemistry |
container_volume | 18 |
creator | Vedula, Manohar Sharma Jennepalli, Sreenu Aryasomayajula, Ratnakar Rondla, Subhash Reddy Musku, Madanmohan Reddy Kura, Rathnakar Reddy Bandi, Parthasaradhi Reddy |
description | Novel nucleosides were synthesized from di benzoyl fluoro lactone (
1) and evaluated their anti-influenza viral activity. Compound (
18c) showed the best antiviral activity among the compounds synthesized.
Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2
R,3
S,4
R,5
R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2
H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate (
18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2
R,3
R,4
R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate (
1) and converting it in to C-3 keto sugar (
7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains. |
doi_str_mv | 10.1016/j.bmc.2010.07.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_749002592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089610006607</els_id><sourcerecordid>749002592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</originalsourceid><addsrcrecordid>eNp9kEtP4zAURi3ECMrjB7BB2SBW6Vw7TmyLFap4SWhmM7O2nNtr4SpNip1UGn79GLXAjtXVJ537OoxdcJhz4M3P1bxd41xAzqDmwNUBm3HZyLKqDD9kMzCNLkGb5pidpLQCACENP2LHAholK8VnrPk1bKkr-gk7GlJYUipcKjbDSP1YhN53E_VvrtiG6LqcX0IbxiGmM_bDuy7R-b6esr_3d38Wj-Xz74enxe1ziZUWY6mkaXXtSXjpFbUooEaHgozX6IyueC25FhKUQ-2Mb6ExGpBERUhKUludsuvd3E0cXidKo12HhNR1rqdhSjYvyE_VRmSS70iMQ0qRvN3EsHbxn-Vg323Zlc227LstC8pmW7nncj99ate0_Oz40JOBqz3gErrOR9djSF9cxU0NjczczY6j7GIbKNqEgXqkZYiEo10O4Zsz_gNpp4dD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749002592</pqid></control><display><type>article</type><title>Novel nucleosides as potent influenza viral inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</creator><creatorcontrib>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</creatorcontrib><description>Novel nucleosides were synthesized from di benzoyl fluoro lactone (
1) and evaluated their anti-influenza viral activity. Compound (
18c) showed the best antiviral activity among the compounds synthesized.
Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2
R,3
S,4
R,5
R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2
H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate (
18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2
R,3
R,4
R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate (
1) and converting it in to C-3 keto sugar (
7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2010.07.017</identifier><identifier>PMID: 20674371</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - chemical synthesis ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Cell Line ; Dogs ; Humans ; Influenza A virus - drug effects ; Influenza B virus - drug effects ; Influenza virus ; Influenza, Human - drug therapy ; Influenza, Human - virology ; Medical sciences ; Nucleosides ; Pharmacology. Drug treatments ; Purine Nucleosides - chemistry ; Purine Nucleosides - pharmacology ; Pyrimidine Nucleosides - chemical synthesis ; Pyrimidine Nucleosides - pharmacology ; SAR ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry, 2010-09, Vol.18 (17), p.6329-6339</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</citedby><cites>FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089610006607$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23195064$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20674371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vedula, Manohar Sharma</creatorcontrib><creatorcontrib>Jennepalli, Sreenu</creatorcontrib><creatorcontrib>Aryasomayajula, Ratnakar</creatorcontrib><creatorcontrib>Rondla, Subhash Reddy</creatorcontrib><creatorcontrib>Musku, Madanmohan Reddy</creatorcontrib><creatorcontrib>Kura, Rathnakar Reddy</creatorcontrib><creatorcontrib>Bandi, Parthasaradhi Reddy</creatorcontrib><title>Novel nucleosides as potent influenza viral inhibitors</title><title>Bioorganic & medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Novel nucleosides were synthesized from di benzoyl fluoro lactone (
1) and evaluated their anti-influenza viral activity. Compound (
18c) showed the best antiviral activity among the compounds synthesized.
Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2
R,3
S,4
R,5
R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2
H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate (
18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2
R,3
R,4
R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate (
1) and converting it in to C-3 keto sugar (
7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Dogs</subject><subject>Humans</subject><subject>Influenza A virus - drug effects</subject><subject>Influenza B virus - drug effects</subject><subject>Influenza virus</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - virology</subject><subject>Medical sciences</subject><subject>Nucleosides</subject><subject>Pharmacology. Drug treatments</subject><subject>Purine Nucleosides - chemistry</subject><subject>Purine Nucleosides - pharmacology</subject><subject>Pyrimidine Nucleosides - chemical synthesis</subject><subject>Pyrimidine Nucleosides - pharmacology</subject><subject>SAR</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtP4zAURi3ECMrjB7BB2SBW6Vw7TmyLFap4SWhmM7O2nNtr4SpNip1UGn79GLXAjtXVJ537OoxdcJhz4M3P1bxd41xAzqDmwNUBm3HZyLKqDD9kMzCNLkGb5pidpLQCACENP2LHAholK8VnrPk1bKkr-gk7GlJYUipcKjbDSP1YhN53E_VvrtiG6LqcX0IbxiGmM_bDuy7R-b6esr_3d38Wj-Xz74enxe1ziZUWY6mkaXXtSXjpFbUooEaHgozX6IyueC25FhKUQ-2Mb6ExGpBERUhKUludsuvd3E0cXidKo12HhNR1rqdhSjYvyE_VRmSS70iMQ0qRvN3EsHbxn-Vg323Zlc227LstC8pmW7nncj99ate0_Oz40JOBqz3gErrOR9djSF9cxU0NjczczY6j7GIbKNqEgXqkZYiEo10O4Zsz_gNpp4dD</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Vedula, Manohar Sharma</creator><creator>Jennepalli, Sreenu</creator><creator>Aryasomayajula, Ratnakar</creator><creator>Rondla, Subhash Reddy</creator><creator>Musku, Madanmohan Reddy</creator><creator>Kura, Rathnakar Reddy</creator><creator>Bandi, Parthasaradhi Reddy</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100901</creationdate><title>Novel nucleosides as potent influenza viral inhibitors</title><author>Vedula, Manohar Sharma ; Jennepalli, Sreenu ; Aryasomayajula, Ratnakar ; Rondla, Subhash Reddy ; Musku, Madanmohan Reddy ; Kura, Rathnakar Reddy ; Bandi, Parthasaradhi Reddy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-749b85fe2f4f7ebc205cac2e9f8ca983154182407ac8a9fb06980ce23ece74eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Dogs</topic><topic>Humans</topic><topic>Influenza A virus - drug effects</topic><topic>Influenza B virus - drug effects</topic><topic>Influenza virus</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - virology</topic><topic>Medical sciences</topic><topic>Nucleosides</topic><topic>Pharmacology. Drug treatments</topic><topic>Purine Nucleosides - chemistry</topic><topic>Purine Nucleosides - pharmacology</topic><topic>Pyrimidine Nucleosides - chemical synthesis</topic><topic>Pyrimidine Nucleosides - pharmacology</topic><topic>SAR</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vedula, Manohar Sharma</creatorcontrib><creatorcontrib>Jennepalli, Sreenu</creatorcontrib><creatorcontrib>Aryasomayajula, Ratnakar</creatorcontrib><creatorcontrib>Rondla, Subhash Reddy</creatorcontrib><creatorcontrib>Musku, Madanmohan Reddy</creatorcontrib><creatorcontrib>Kura, Rathnakar Reddy</creatorcontrib><creatorcontrib>Bandi, Parthasaradhi Reddy</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vedula, Manohar Sharma</au><au>Jennepalli, Sreenu</au><au>Aryasomayajula, Ratnakar</au><au>Rondla, Subhash Reddy</au><au>Musku, Madanmohan Reddy</au><au>Kura, Rathnakar Reddy</au><au>Bandi, Parthasaradhi Reddy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel nucleosides as potent influenza viral inhibitors</atitle><jtitle>Bioorganic & medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>18</volume><issue>17</issue><spage>6329</spage><epage>6339</epage><pages>6329-6339</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Novel nucleosides were synthesized from di benzoyl fluoro lactone (
1) and evaluated their anti-influenza viral activity. Compound (
18c) showed the best antiviral activity among the compounds synthesized.
Influenza virus infection constitutes a significant health problem in need of more effective therapies. We have recently identified ((2
R,3
S,4
R,5
R)-3-acetoxy-5-(4-benzamido-2-oxopyrimidin-1(2
H)-yl)-4-fluoro-3,4-dimethyl-tetrahydrofuran-2-yl) methyl benzoate (
18c) as a potent influenza virus inhibitor. We now here report the synthesis and evaluation of a series of C-3′ modified ribose nucleosides. These novel compounds were prepared, primarily by taking known ((2
R,3
R,4
R)-3-benzoyloxy-4-fluoro-4-methyl-5-oxo-tetrahydrofuran-2-yl)methyl benzoate (
1) and converting it in to C-3 keto sugar (
7), reacting C-3 keto group with methyl magnesium bromide, followed by coupling these sugars with purine and pyrimidine bases. Anti influenza viral activity was determined by screening against both A and B viral strains.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20674371</pmid><doi>10.1016/j.bmc.2010.07.017</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0968-0896 |
ispartof | Bioorganic & medicinal chemistry, 2010-09, Vol.18 (17), p.6329-6339 |
issn | 0968-0896 1464-3391 |
language | eng |
recordid | cdi_proquest_miscellaneous_749002592 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - chemical synthesis Antiviral Agents - pharmacology Biological and medical sciences Cell Line Dogs Humans Influenza A virus - drug effects Influenza B virus - drug effects Influenza virus Influenza, Human - drug therapy Influenza, Human - virology Medical sciences Nucleosides Pharmacology. Drug treatments Purine Nucleosides - chemistry Purine Nucleosides - pharmacology Pyrimidine Nucleosides - chemical synthesis Pyrimidine Nucleosides - pharmacology SAR Structure-Activity Relationship |
title | Novel nucleosides as potent influenza viral inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A48%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20nucleosides%20as%20potent%20influenza%20viral%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Vedula,%20Manohar%20Sharma&rft.date=2010-09-01&rft.volume=18&rft.issue=17&rft.spage=6329&rft.epage=6339&rft.pages=6329-6339&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2010.07.017&rft_dat=%3Cproquest_cross%3E749002592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749002592&rft_id=info:pmid/20674371&rft_els_id=S0968089610006607&rfr_iscdi=true |